Xcout Intel
Omniox, Inc.
Omniox, Inc. is an early-stage biopharmaceutical company located in San Francisco, California, focused on developing new medicines for hypoxic diseases.
Subscribe to see Omniox, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Omniox, Inc. at a glance
Omniox, Inc. is a drug discovery company headquartered in United States. It has raised at least $27.1M across the 2 funding rounds on record. Its most recent funding round raised $24.1M in July 2016. Xcout tracks 3 named people at Omniox, Inc., including Jonathan Winger (CEO).
Omniox, Inc. leadership
- Jonathan WingerCEO
- Jonathan WingerCo-Founder and CEO
- Julia SimmonsSenior Director, Controller
Omniox, Inc. funding rounds
At least $27.1M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $24.1M | — | |
| — | $3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Omniox, Inc. competitors
A few of Omniox, Inc.'s closest competitors — see the full list of competitors and alternatives →
KayoThera, Inc. is an early-stage, preclinical therapeutics company headquartered in Seattle, Washington. The firm focuses on developing first-in-class, oral, small molecule treatments.
Kinoxis Therapeutics Pty Ltd is an Australian-based, clinical-stage biotechnology company that develops first-in-class therapeutics targeting ALOX15 to address central nervous system (CNS) diseases.
Glycomine, Inc. is a biotherapeutics company focused on developing replacement therapies and treatments for serious rare genetic diseases, operating out of major life science hubs in San Francisco and Boston.
AllIn Bio is a drug discovery company headquartered in Woodside, California. The firm is developing a precision-immunology approach designed to treat the root cause of chronic inflammatory diseases.
OncoMyx Therapeutics, Inc. is a biotechnology company headquartered in Phoenix, Arizona, that develops innovative oncolytic immunotherapies to target and destroy tumors.
Get Omniox, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Omniox, Inc. in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access